Abstract
This analysis is based on a series of in-depth interviews conducted in Northern California, United States, during a pilot study focusing on young peoples’ perspectives on sexual health, particularly as it relates to HIV. Among our sample, we interviewed HIV seronegative young men and women who were romantically involved with partners who were living with HIV (n = 9). In this analysis, we attend to the local and practical concerns of these participants and examine the ways in which they envisioned a new biomedical HIV prevention technology – PrEP – shaping their experience of serodiscordance. We explore the similarities and differences in the ways that young seronegative partners, both heterosexuals and gay, talk about their identity as a member of a serodiscordant couple. In particular, we foreground PrEP’s role in the production of hope as it emerged in the discourse of these youth. With PrEP – a highly effective HIV prevention strategy – some of the threatening meanings ascribed to the virus receded; in their place, language reflecting hope and optimism appeared. This phenomenon signals that PrEP, as part of a new wave of biomedical interventions, is shifting people’s relationship to HIV and, as a consequence, relationship dynamics and perceptions of serodiscordance are evolving.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
At the time of this research, PrEP was not easily available, insurance companies had not officially added it to their formularies, and PrEP users were primarily white gay men participating in PrEP research studies or had the resources to pay for it out of pocket.
- 2.
Though commonly practiced, this is not an effective HIV prevention (or pregnancy prevention) strategy.
References
AIDS Healthcare Foundation. (2014). An open letter to the Centers for Disease Control: what if you’re wrong about PrEP? AIDS Healthcare Foundation. http://www.aidshealth.org/wp-content/uploads/2014/11/PrEP-CDC-Open-Letter-What-if-Youre-Wrong-on-PrEP-ad-11-2014-DT1.pdf Accessed 6 May 2015.
Auerbach, J. D., & Hoppe, T. A. (2015). Beyond “getting drugs into bodies”: Social science perspectives on pre-exposure prophylaxis for HIV. Journal of the International AIDS Society, 18(4 Suppl 3), 19983.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., the Partners PrEP Study Team, et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., the HPTN 052 Study Team, et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505.
Godfrey, C. (2015). Why we need PrEP: Four gay men share their views on the HIV prevention drug. Independent. http://www.independent.co.uk/life-style/health-and-families/features/why-we-need-prep-four-gay-men-share-their-views-on-the-hiv-prevention-drug-10435823.html Accessed 4 Aug 2015.
Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. New York: Simon and Schuster.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., the iPrEx Study Team, et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.
Jacobs, D. (2015). A PrEP users perspective. Paper presented at IAS2015: The International AIDS Society Conference, Vancouver, Canada. http://www.ias2015.org/webcontent/file/pag/Monday/Monday.pdf
Jacoby, A. (1994). Felt versus enacted stigma: A concept revisited. Evidence from a study of people with epilepsy in remission. Social Science and Medicine, 38(2), 269–274.
Kippax S. (2010). Reasserting the social in a biomedical epidemic: The case of HIV-prevention. Presented at the workshop: Reframing the Social Dimensions of HIV in a Biomedicalised Epidemic: The Case of Treatment as Prevention. London: Overseas Development Institute.
Koester, K. A., & Grant, R. M. (2015). Keeping our eyes on the prize: No new HIV infections with increased use of HIV pre-exposure prophylaxis. Clinical Infectious Disease, 61(10), 1604–1605.
Koester, K., Amico, R., Liu, A., McMahan, V., Hosek, S., Mayer, K., et al. (2014). Sex on PrEP: Qualitative findings from the iPrEx Open Label Extension (OLE) in the United States. Paper presented at AIDS2014: The International AIDS conference, Melbourne.
Nguyen, V. K., Bajos, N., Dubois-Arber, F., O’Malley, J., & Pirkle, C. M. (2011). Remedicalizing an epidemic: From HIV treatment as prevention to HIV treatment is prevention. AIDS, 25(3), 291–293.
Patton, C. (1990). Inventing AIDS. New York: Routledge.
Persson, A. (2008). Sero-silence and sero-sharing: Managing HIV in serodiscordant heterosexual relationships. AIDS Care, 20(4), 503–506.
Persson, A. (2013). Non/infectious corporealities: Tensions in the biomedical era of “HIV normalisation”. Sociology of Health & Illness, 35(7), 1065–1079.
Persson, A. (2015). “The world has changed”: Pharmaceutical citizenship and the reimagining of serodiscordant sexuality among couples with mixed HIV status in Australia. Sociology of Health & Illness, 38(3), 380–395.
Potts, A. (2004). Deleuze on Viagra (or, what can a “Viagra-body” do?). Body & Society, 10(1), 17–36.
Race, K. (2009). Pleasure consuming medicine: The queer politics of drugs. Durham: Duke University Press.
Richardson, R., Golden, S., & Hanssens, C. (2015). Ending and defending against HIV criminalization: A manual for advocates. Vol. 1: State and federal laws and prosecutions (2nd ed.). New York: The Center for HIV Law and Policy.
Rosengarten, M. (2009). HIV interventions: Biomedicine and the traffic between information and flesh. Seattle: University of Washington Press.
Rosengarten, M., & Michael, M. (2009). The performative function of expectations in translating treatment to prevention: The case of HIV pre-exposure prophylaxis, or PrEP. Social Science & Medicine, 69(7), 1049–1055.
Sidibé, M. (2011). Game changing year: 2011 World AIDS Day message. Geneva: UNAIDS.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., the TDF2 Study Group, et al. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434.
Treichler, P. A. (1999). How to have theory in an epidemic: Cultural chronicles of AIDS. Durham: Duke University Press.
Ware, N. C., Wyatt, M. A., Haberer, J. E., Baeten, J. M., Kintu, A., Psaros, C., et al. (2012). What’s love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. Journal of Acquired Immune Deficiency Syndromes, 59(5), 463–468.
Watney, S. (1997). Policing desire: Pornography, AIDS and the media. Minneapolis: University of Minnesota Press.
Young, I., Flowers, P., & McDaid, L. M. (2014). Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: Findings from a qualitative study in Scotland. BMJ Open, 4(11), e005717.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Koester, K.A., Erguera, X.A., Myers, J.J. (2017). “PrEP Makes My Relationship Even More Normal:” The Discursive Production of Hope in the Context of HIV Pre-exposure Prophylaxis Among Young Adults with Partners Living with HIV Infection. In: Persson, A., Hughes, S. (eds) Cross-Cultural Perspectives on Couples with Mixed HIV Status: Beyond Positive/Negative. Social Aspects of HIV, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-319-42725-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-42725-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42723-2
Online ISBN: 978-3-319-42725-6
eBook Packages: MedicineMedicine (R0)